University Medical Center Ho Chi Minh City (UMC)
WebsiteOverview
A public university hospital run on a school-hospital model under the University of Medicine and Pharmacy at Ho Chi Minh City, established in 1994 and formalised under Decision 3639/2000/QĐ-BYT; campus 2 (since around 2020) has about 1,000 beds.
It has no centralised cancer centre but is organised across specialties - the Department of Cancer Chemotherapy, the Breast Department and the Department of Gastrointestinal Surgery - working together through multidisciplinary case review.
Liver transplants rose 44% in 2025, passing 100 cumulative liver transplants using the split-liver technique from brain-dead donors - hepatobiliary surgical capability relevant to the treatment of liver cancer.
Scale
Scale: campus 2 has about 1,000 beds (no consistent total figure across the 3 campuses). Outpatients system-wide: ~2-2.7 million visits per year; inpatients: ~55,000-120,000 cases per year; operations: ~30,000-44,000 per year (not broken down for oncology).
Accreditation
February 2025: certification under the PRIME-JCI programme (prevention of infection and of intravenous medication errors) - not hospital-wide JCI accreditation. ISO 15189:2022 for diagnostic imaging/laboratory testing at 4 units (campus 2, signed 27 February 2026). No hospital-wide JCI Hospital Accreditation.
Strengths and key treatments
The Breast Department is led by Dr Nguyễn Triệu Vũ (Level II specialist), who trained at MD Anderson Cancer Center, Memorial Sloan Kettering and Harvard Medical School and is a member of ASCO, ESMO and SSO.
Liver transplants rose 44% in 2025, passing 100 cumulative liver transplants, using the "full right - full left" split-liver technique from brain-dead donors.
A separate Department of Cancer Chemotherapy; a radiotherapy linear accelerator, PET/CT or surgical robot dedicated to oncology has not been specifically confirmed.
The team includes Dr Nguyễn Triệu Vũ (Level II specialist) - Head of the Breast Department.
Oncologists
Head of the Breast Department, University Medical Center Ho Chi Minh City; advanced training at MD Anderson Cancer Center, Memorial Sloan Kettering and Harvard Medical School; member of ASCO, ESMO and SSO.